Ovarian Cancer
Medicine and Dentistry
100%
Cancer Cell
Biochemistry, Genetics and Molecular Biology
67%
Ovary Cancer
Pharmacology, Toxicology and Pharmaceutical Science
57%
Ceramide
Medicine and Dentistry
42%
Cell Motility
Biochemistry, Genetics and Molecular Biology
36%
Cells
Medicine and Dentistry
36%
Cisplatin
Biochemistry, Genetics and Molecular Biology
36%
Combination Therapy
Medicine and Dentistry
32%
Endo, S. ,
Shigeta, S. ,
Tokunaga, H. ,
Shimizu, T. ,
Hasegawa-Minato, J. ,
Hashimoto, C. ,
Ishibashi, M. ,
Nagai, T. ,
Shiga, N. ,
Shimada, M. &
Yaegashi, N. ,
2022 ,
In: Tohoku Journal of Experimental Medicine. 258 ,
1 ,
p. 1-9 9 p. 研究成果: Article › 査読
Olaparib
100%
Maintenance Therapy
71%
Recurrent Ovarian Cancer
35%
Treatment Duration
28%
Progression Free Survival
21%
Shigeta, S. ,
Watanabe, Y. ,
Suzuki, F. ,
Nagase, S. ,
Shibuya, Y. ,
Ishibashi, M. ,
Nagai, T. ,
Shiga, N. ,
Toyoshima, M. ,
Tokunaga, H. ,
Shimada, M. &
Yaegashi, N. ,
2022 ,
In: Tohoku Journal of Experimental Medicine. 256 ,
3 ,
p. 249-258 10 p. 研究成果: Article › 査読
MicroRNA
100%
Cell Motility
46%
Matrix Metalloproteinase
38%
Transfection
15%
Precursor
15%
Watanabe, Z. ,
Tokunaga, H. ,
Ishibashi, M. ,
Shigeta, S. ,
Tsuji, K. ,
Nagai, T. ,
Tachibana, M. ,
Shimada, M. &
Yaegashi, N. ,
2021 2月 15 ,
In: European Journal of Gynaecological Oncology. 42 ,
1 ,
p. 183-188 6 p. 研究成果: Article › 査読
Cervicectomy
100%
Amputation
66%
Cervix
50%
Recurrent Disease
33%
Neoplasm
33%
Toyoshima, M. ,
Shimada, M. ,
Sasaki, S. ,
Ishibashi, M. ,
Shigeta, S. ,
Tsuji, K. ,
Nagai, T. ,
Tokunaga, H. ,
Niikura, H. &
Yaegashi, N. ,
2021 ,
In: Tohoku Journal of Experimental Medicine. 254 ,
3 ,
p. 145-153 9 p. 研究成果: Article › 査読
Bevacizumab
100%
Chemotherapy
77%
Uterine Cervix Cancer
44%
Adverse Event
33%
Monotherapy
33%
Zhang, X. ,
Sakamoto, W. ,
Canals, D. ,
Ishibashi, M. ,
Matsuda, M. ,
Nishida, K. ,
Toyoshima, M. ,
Shigeta, S. ,
Taniguchi, M. ,
Senkal, C. E. ,
Okazaki, T. ,
Yaegashi, N. ,
Hannun, Y. A. ,
Nabe, T. &
Kitatani, K. ,
2021 2月 ,
In: FASEB Journal. 35 ,
2 , e21287.
研究成果: Article › 査読
Ceramide
100%
Lamellipodium
42%
Cell Motility
28%
Electric Potential
21%
Cancer Cell
21%